AlphaYou
Overview
Smart money at a glance
Filings to Oct 4, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- 8 awardsAwards on record
Market overview
Fundamentals Oct 4- Open
- $46.88
- 52-wk high
- $53.66
- High
- $47.06
- 52-wk low
- $31.44
- Low
- $46.16
- Prev close
- $45.93
- Mkt cap
- $1.39B
- P/E
- 25.0x
- Volume
- 240.7K
- Fwd P/E
- 27.2x
- Beta
- 0.91
- P/S
- 1.0x
- P/B
- 1.3x
- Profit margin
- +4.1%
- Op margin
- +14.6%
- ROE
- +5.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CNMD filings
Are insiders buying or selling CONMED Corporation (CNMD) stock?
Neither. CONMED Corporation (CNMD) insiders filed no open-market purchases or sales in the 90 days to Oct 4, 2026, according to SEC Form 4 filings.
Which members of Congress have traded CNMD recently?
None. No member of Congress disclosed a CNMD trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CNMD smart-money data?
This summary uses filings available on Oct 4, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (2)
- LA
LSV Asset
$12.7M
added
- TS
Two Sigma
$16.6M
added
Sells/Trims (1)
- CI
Citadel
$17.3M
trimmed
How top traders are positioned
No tracked top-trader positions in CNMD right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 25.5% above what analysts expected.
Last report
Jul 29, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.10 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $1.38 / $1.10Alpha Vantage | +25.45% beat | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 29, 2026 | $0.89 / $0.82Alpha Vantage | +8.54% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Jan 28, 2026 | $1.43 / $1.32Alpha Vantage | +8.33% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 5, 2025 | $1.08 / $1.05Alpha Vantage | +2.86% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 30, 2025 | $1.15 / $1.12Alpha Vantage | +2.68% beat | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 30, 2025 | $0.95 / $0.81Alpha Vantage | +17.28% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 5, 2025 | $1.34 / $1.20Alpha Vantage | +11.67% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 30, 2024 | $1.05 / $1.00Alpha Vantage | +5.00% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 4, 2026, in 31 days
Financials
Is the business strong?
Reasonably priced and running thin margins.
- Net margin
- 4.1%
- P/E
- 25.04
- Forward P/E
- 27.17
- Market cap
- $1.4B
Valuation
- P/S1.01
- P/B1.33
Quality
- Operating margin14.6%
- ROE5.5%
- ROA4.1%
Growth
- Beta0.91
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace